BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16630055)

  • 1. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting.
    Li X; Lu F; Wang JZ; Gong CX
    Eur J Neurosci; 2006 Apr; 23(8):2078-86. PubMed ID: 16630055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.
    Liu F; Shi J; Tanimukai H; Gu J; Gu J; Grundke-Iqbal I; Iqbal K; Gong CX
    Brain; 2009 Jul; 132(Pt 7):1820-32. PubMed ID: 19451179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain.
    Fujimura M; Usuki F; Sawada M; Takashima A
    Neurotoxicology; 2009 Nov; 30(6):1000-7. PubMed ID: 19666049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease.
    Liu Y; Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
    FEBS Lett; 2008 Jan; 582(2):359-64. PubMed ID: 18174027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau.
    Yu CH; Si T; Wu WH; Hu J; Du JT; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2008 Oct; 375(1):59-62. PubMed ID: 18671940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
    Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
    Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease.
    Liu F; Liang Z; Gong CX
    Panminerva Med; 2006 Jun; 48(2):97-108. PubMed ID: 16953147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.
    Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
    Eur J Neurosci; 2005 Oct; 22(8):1942-50. PubMed ID: 16262633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2006 Mar; 9(1):1-12. PubMed ID: 16627930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats.
    Head E; Moffat K; Das P; Sarsoza F; Poon WW; Landsberg G; Cotman CW; Murphy MP
    Neurobiol Aging; 2005 May; 26(5):749-63. PubMed ID: 15708450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.
    Deng Y; Li B; Liu Y; Iqbal K; Grundke-Iqbal I; Gong CX
    Am J Pathol; 2009 Nov; 175(5):2089-98. PubMed ID: 19815707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain.
    Wang DL; Ling ZQ; Cao FY; Zhu LQ; Wang JZ
    J Pineal Res; 2004 Aug; 37(1):11-6. PubMed ID: 15230863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.
    Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
    J Neurochem; 2009 Oct; 111(1):242-9. PubMed ID: 19659459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cortistatin on tau phosphorylation at Ser262 site.
    Rubio A; PĂ©rez M; de Lecea L; Avila J
    J Neurosci Res; 2008 Aug; 86(11):2462-75. PubMed ID: 18438934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.
    Huang R; Tian S; Zhang H; Zhu W; Wang S
    Brain Res Bull; 2020 Mar; 156():76-85. PubMed ID: 31931119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress.
    Feng Q; Cheng B; Yang R; Sun FY; Zhu CQ
    Neurosci Lett; 2005 Nov; 388(1):13-6. PubMed ID: 16005567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.